UMIN-CTR History

Name：　　UMIN ID：


Unique ID issued by UMIN UMIN000005918
Receipt number R000006999
Scientific Title Phase 2 study of fix dose rate gemcitabine plus S-1 with advanced biliary tract cancer refractory to standard dose rate gemcitabine
Date of disclosure of the study information 2011/07/05
Last modified on 2017/07/10 16:08:10

No. Disposal Last modified on Item of update
1 Insert 2011/07/05 01:38:14
2 Update 2011/10/14 21:01:51 Acronym
Acronym
3 Update 2011/10/14 21:05:48 Key inclusion criteria
Key inclusion criteria
4 Update 2011/10/14 21:07:42 Institutions
5 Update 2012/01/05 11:00:59 Key exclusion criteria
Key exclusion criteria
6 Update 2014/01/06 07:37:39 Address
Address
TEL
Email
Address
Address
Email
Address
Address
TEL
Address1
Tel1
Institutions
7 Update 2015/01/05 16:25:44 Recruitment status
Last follow-up date
8 Update 2016/01/05 18:45:15 Date of closure to data entry
Date trial data considered complete
Date analysis concluded
9 Update 2016/07/05 11:47:53 Name of primary person or sponsor
Organization
10 Update 2016/12/11 10:14:38 Publication of results
11 Update 2017/01/07 12:07:24 URL related to results and publications
Results
12 Update 2017/07/10 16:08:10 Recruitment status
Publication of results